Primary hyPerParathyroidism (pHPT) is a disease for which the diagnosis and treatment have become relatively straightforward. The criteria for diagnosis have become standardized with either elevated blood calcium levels, the presence of kidney stones, or decreased bone densitometry. The primary causes of pHPT are classically said to be 80%-85% due to adenoma, 10% -15% due to hyperplasia, and ~1% due to carcinoma, respectively. Majority of responsible lesion of pHPT is, thus, a single adenoma. The standard of care of pHPT is a surgical excision of the responsible lesion(s). Therefore, accurate localiza- abstract. We evaluated the efficacy of technetium-sestamibi ( 99m Tc-MIBI) SPECT/CT for planning parathyroidectomy in cases with primary hyperparathyroidism (pHPT), comparing with planar scintigraphy and ultrasound (US), in an aim to establish the proper surgical strategy according to the preoperative imaging studies. A retrospective review of consecutive 75 pHPT patients who had been operated on was conducted. The results of preoperative imaging modalities and the operative finding were analyzed. Seven cases were found to have multiple hyperplastic glands, and no responsible gland was found in three cases. Four cases underwent only US scan for preoperative imaging. Remaining 61 cases were found to have single adenoma, and were included in the evaluation of localization imaging. US scan, 99m Tc-MIBI planar scan and 99m Tc-MIBI SPECT/CT showed accurate localization in 77.0% (47/61), 75.4% (46/61) and 88.5% (46/52) of the evaluable cases, respectively. US and 99m Tc-MIBI planar scan demonstrated consistent result in 42 cases (68.9%), and those cases showed accurate localization in 90.5% (38/42). When both US and 99m Tc-MIBI SPECT/CT was consistent, all 37 lesions had been correctly indicated. No clinico-pathological features were suggested to influence in demonstrating the localization, other than only 99m Tc-MIBI SPECT/CT exhibited 100% sensitivity in ectopic glands. Combination of US and 99m Tc-MIBI SPECT/CT certainly contributes to the planning of minimally invasive operation in cases with pHPT by indicating correct localization of single adenoma.Key words: Primary hyperparathyroidism, Technetium-sestamibi ( 99m Tc-MIBI), SPECT/CT tion analysis is important.The imaging techniques that have been used to identify the location of responsible lesion(s) are technetium-thallium subtraction scan, technetium-sestamibi ( 99m Tc-MIBI) scan, ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT) [1], venous sampling of parathyroid hormone, and angiography. To date, the best results have been found using either US or technetium imaging.The sensitivity of US for detecting a single parathyroid adenoma was 57 to 87 % [2][3][4][5][6][7]. However, parathyroid US is dependent on the experience of the operator [8] and has a suboptimal detection rate for multinodular thyroid disease and silent areas, such as the mediastinum, tracheoesophageal groove, and retroesophageal region [9]. Therefore, the practical choic...